Adult female rats were implanted with permanent cannulae in the third ventricle of the brain and allowed to recover regular 4-day estrous cycles. They received intrajugular cannulae on the morning of proestrus and later between 12.00–13.00 h catecholamines – norepinephrine (NE; 5.3 or 15.9 µg), dopamine (DA; 5.3 µg), epinephrine (E; 5.3 or 15.9 µg) or vehicle (artificial CSF) – were administered intraventricularly. Plasma LH levels were measured in blood samples obtained prior to and 10, 20, 30 or 60 min after catecholamine injections. While NE or DA failed to alter basal plasma LH levels, E evoked a significant 2-fold rise in plasma LH levels. Quite unexpectedly, however, infusion of E (18.5 µg) over a 30-min period during the critical period failed to either reverse the pentobarbital-blockade of ovulation or stimulate LH release. Prior suppression of E levels selectively with LY 78335 blocked the preovulatory LH surge and ovulation. However, intraventricular E failed to evoke LH release in these LY 78335-blocked proestrous rats, an observation suggestive of some α1-adrenoreceptor blocking action of the drug. In contrast, the α1-adrenoreceptor blocking action was not evident in the estrogen, progesterone-primed ovariectomized rats similarly pretreated with LY 78335. These studies show that (1) E-containing neurons in the hypothalamus may play an important role in the preovulatory LH release; (2) LY 78335 may exert inhibitory effects on preovulatory LH release, in part, by blocking α1-adrenoreceptors, and (3) participation of NE and DA, if any, in evoking preovulatory LH release remains to be ascertained.

Keywords:
Epinephrine, Norepinephrine, Dopamine, Preovulatory LH, Ovulation
This content is only available via PDF.
© 1985 S. Karger AG, Basel
1985
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.